| |
| |
|
| Insider
Information: |
Lewis Joel |
| Relationship: |
|
| City: |
Norcross |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
897,012 |
|
|
Indirect Shares
|
2,000 |
|
|
| Direct
Value |
$2,735,887 |
|
|
|
Indirect Value
|
$6,100 |
|
|
| Total
Shares |
899,012 |
|
|
| Total
Value |
$2,741,987 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 13.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
|
2024-04-24 |
897,012 |
2024-04-24 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2024-03-01 |
4 |
A |
$1.96 |
$299,065 |
D/D |
152,584 |
897,716 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-01-31 |
4 |
A |
$1.93 |
$216,668 |
D/D |
112,263 |
420,131 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-02-07 |
4 |
A |
$1.43 |
$205,685 |
D/D |
143,836 |
873,140 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-03-01 |
4 |
D |
$2.07 |
$156,345 |
D/D |
(75,529) |
820,299 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2021-03-05 |
4 |
A |
$2.22 |
$60,000 |
D/D |
27,027 |
214,684 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2020-01-09 |
4 |
A |
$2.86 |
$58,501 |
D/D |
20,455 |
99,104 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-01-16 |
4 |
A |
$4.72 |
$55,002 |
D/D |
11,653 |
63,133 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2017-12-14 |
4 |
A |
$2.39 |
$55,001 |
D/D |
23,013 |
50,880 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-05-31 |
4 |
B |
$4.28 |
$54,994 |
D/D |
12,849 |
78,649 |
2.39 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-07-29 |
4 |
A |
$2.26 |
$23,970 |
D/D |
10,606 |
552,139 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-10-13 |
4 |
A |
$2.01 |
$20,170 |
D/D |
10,035 |
989,025 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-02-28 |
4 |
A |
$2.07 |
$19,268 |
D/D |
9,308 |
895,828 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-02-15 |
4 |
A |
$1.44 |
$19,267 |
D/D |
13,380 |
886,520 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-04-28 |
4 |
A |
$1.76 |
$19,267 |
D/D |
10,947 |
860,146 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-05-15 |
4 |
A |
$1.64 |
$19,267 |
D/D |
11,748 |
871,894 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-05-31 |
4 |
A |
$1.57 |
$19,267 |
D/D |
12,272 |
884,166 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-06-30 |
4 |
A |
$1.44 |
$19,267 |
D/D |
13,380 |
911 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-07-14 |
4 |
A |
$1.63 |
$19,267 |
D/D |
11,820 |
922,562 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-08-15 |
4 |
A |
$1.60 |
$19,267 |
D/D |
12,042 |
947,448 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-09-15 |
4 |
A |
$1.76 |
$19,267 |
D/D |
10,947 |
969,405 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-09-29 |
4 |
A |
$1.92 |
$19,267 |
D/D |
10,035 |
979,440 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-11-15 |
4 |
A |
$1.87 |
$19,267 |
D/D |
10,303 |
1,008,772 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-12-15 |
4 |
A |
$1.60 |
$19,267 |
D/D |
12,042 |
1,030,694 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-03-15 |
4 |
A |
$1.90 |
$19,266 |
D/D |
10,140 |
830,439 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-04-14 |
4 |
A |
$2.01 |
$19,266 |
D/D |
9,585 |
849,199 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
